Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01122576 · ClinicalTrials.gov registry record · Phase 4
Evaluation of 3 Intraocular Lenses Following Lens Extraction
A Phase 4 study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- Phase 4
- Development phase
- 78
- Enrollment target
NCT01122576 is a Phase 4 study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 78 participants.
The verdict
NCT01122576, a Phase 4 study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 78 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the efficacy and subject satisfaction with three different FDA approved lenses for adults over 40 years of age who desire a reduction in spectacle dependence.
Interventions
- DEVICE ReSTOR
- DEVICE Tecnis Multifocal IOL
- DEVICE Crystalens AO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01122576
The ClinicalTrials.gov registry entry for NCT01122576 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which ReSTOR is the first listed.
NCT01122576 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01122576 about?
NCT01122576 is a clinical study titled "Evaluation of 3 Intraocular Lenses Following Lens Extraction". The objective of this study is to evaluate the efficacy and subject satisfaction with three different FDA approved lenses for adults over 40 years of age who desire a reduction in spectacle dependence.
What is the current status of trial NCT01122576?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 78 participants. The study started on 2010-06. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01122576?
The interventions under investigation include: ReSTOR (DEVICE), Tecnis Multifocal IOL (DEVICE), Crystalens AO (DEVICE).
Who is sponsoring clinical trial NCT01122576?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.